U. Missling Christopher's most recent trade in Anavex Life Sciences Corporation was a trade of 125,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 06 Jan 2026 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | ||
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 02 Oct 2025 | 125,000 | 250,000 | - | - | Stock Option (Right to Buy) | ||
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 11 Sep 2025 | 187,500 | 0 | - | - | Stock Option (Right to Buy) | ||
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 11 Sep 2025 | 187,500 | 1,655,213 (2%) | 0% | 5.0 | 945,000 | Common Stock | |
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 11 Sep 2025 | 145,048 | 1,510,165 (2%) | 0% | 9.6 | 1,389,560 | Common Stock | |
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 20 Aug 2025 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | ||
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 28 Apr 2025 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | ||
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 24 Mar 2025 | 500,000 | 1,750,210 (2%) | 0% | 0.9 | 460,000 | Common Stock | |
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 24 Mar 2025 | 500,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 24 Mar 2025 | 282,497 | 1,467,713 (2%) | 0% | 9.6 | 2,720,446 | Common Stock | |
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 15 Jan 2025 | 166,666 | 166,000 | - | - | Stock Option (Right to Buy) | ||
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 15 Jan 2025 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | ||
| Anavex Life Sciences Corp | U. Christopher Missling | Director, President and CEO | 19 Dec 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | ||
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 19 Nov 2024 | 125,000 | 250,000 | - | - | Stock Option (Right to Buy) | ||
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 28 Mar 2024 | 73,380 | 0 | - | - | Stock Option (Right to Buy) | ||
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 28 Mar 2024 | 73,380 | 1,250,210 (2%) | 0% | 5.1 | 374,972 | Common Stock | |
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 28 Mar 2024 | 73,380 | 1,323,590 (2%) | 0% | 1.3 | 96,862 | Common Stock | |
| Anavex Life Sciences Corp | U. Missling Christopher | Director, President and CEO | 02 Jan 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | ||
| Anavex Life Sciences Corp | Christopher U. Missling | Director, Chief Executive Officer | 02 Aug 2021 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) |